NL8105073A - Farmacologische toebereiding van fructose-1,6-difosfaat met therapeutische werking op patienten met brandwonden. - Google Patents
Farmacologische toebereiding van fructose-1,6-difosfaat met therapeutische werking op patienten met brandwonden. Download PDFInfo
- Publication number
- NL8105073A NL8105073A NL8105073A NL8105073A NL8105073A NL 8105073 A NL8105073 A NL 8105073A NL 8105073 A NL8105073 A NL 8105073A NL 8105073 A NL8105073 A NL 8105073A NL 8105073 A NL8105073 A NL 8105073A
- Authority
- NL
- Netherlands
- Prior art keywords
- patients
- burns
- fructose
- diphosphate
- pharmacological preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT47554/81A IT1170618B (it) | 1981-01-13 | 1981-01-13 | Preparato farmacologico di frutto sio-1,6-difosfato ad azione terapeutica nei pazienti ustionati |
| IT4755481 | 1981-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8105073A true NL8105073A (nl) | 1982-08-02 |
Family
ID=11261053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8105073A NL8105073A (nl) | 1981-01-13 | 1981-11-10 | Farmacologische toebereiding van fructose-1,6-difosfaat met therapeutische werking op patienten met brandwonden. |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS57139016A (it) |
| AU (1) | AU7889081A (it) |
| BE (1) | BE891316A (it) |
| DE (1) | DE3150527A1 (it) |
| FR (1) | FR2497667A1 (it) |
| GB (1) | GB2092001B (it) |
| IT (1) | IT1170618B (it) |
| LU (1) | LU83808A1 (it) |
| NL (1) | NL8105073A (it) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156103B (it) * | 1982-07-02 | 1987-01-28 | Foscama Biomed Chim Farma | Preparato di fruttosio-1,6-difosfato ad azione antiallergica |
| IT1164363B (it) * | 1983-08-03 | 1987-04-08 | Foscama Biomed Chim Farma | Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi |
| IT1204764B (it) * | 1986-01-17 | 1989-03-10 | Foscama Biomed Chim Farma | Utilizzazione terapeutica del fruttosio-1,6-difosfato per la protezione nei confronti della tossicita' indotta da somministrazione di antitumorali antraciclinici |
| US4847078A (en) * | 1987-01-14 | 1989-07-11 | Arseco, Inc. | Storage stable topical composition having moisture control agent |
| CA2016709A1 (en) * | 1989-05-15 | 1990-11-15 | University Of Cincinnati | Stable aqueous solution having high concentrations of calcium and phosphate ions and solid complex |
| GB9205800D0 (en) * | 1992-03-17 | 1992-04-29 | British Tech Group | Treatment of fibrotic disorders |
| KR100836033B1 (ko) * | 2002-05-27 | 2008-06-09 | (주)아모레퍼시픽 | 프럭토스 1,6-디포스페이트 또는 그 유도체를 함유한미백용 피부외용제 조성물 |
| ITPD20060082A1 (it) * | 2006-03-13 | 2007-09-14 | Laura Martelli | Composizione ad uso cosmetico o dermatologico |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6065M (it) * | 1966-11-25 | 1968-05-27 | ||
| US3931402A (en) * | 1970-12-02 | 1976-01-06 | Societa Prodotti Antibiotici S.P.A. | Preparations containing hexoses |
| DE2508474A1 (de) * | 1975-02-27 | 1976-09-02 | Boehringer Mannheim Gmbh | Infusions- und spuelfluessigkeiten zur behandlung von hirnoedemen |
| IT1162443B (it) * | 1979-01-16 | 1987-04-01 | Foscama Biomed Chim Farma | Sale ferrico del fruttosio-1,6-difosfato procedimento per la sua produzione e sua utilizzazione nella preparazione dell'acido fruttosio-1,6-difosforico |
| IT1143956B (it) * | 1980-03-12 | 1986-10-29 | Foscama Biomed Chim Farma | Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea |
-
1981
- 1981-01-13 IT IT47554/81A patent/IT1170618B/it active
- 1981-11-10 NL NL8105073A patent/NL8105073A/nl not_active Application Discontinuation
- 1981-12-01 BE BE0/206709A patent/BE891316A/fr not_active IP Right Cessation
- 1981-12-03 LU LU83808A patent/LU83808A1/fr unknown
- 1981-12-21 DE DE19813150527 patent/DE3150527A1/de not_active Withdrawn
- 1981-12-24 AU AU78890/81A patent/AU7889081A/en not_active Abandoned
- 1981-12-30 FR FR8124524A patent/FR2497667A1/fr active Pending
-
1982
- 1982-01-07 GB GB8200440A patent/GB2092001B/en not_active Expired
- 1982-01-12 JP JP57003986A patent/JPS57139016A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT8147554A0 (it) | 1981-01-13 |
| AU7889081A (en) | 1982-07-22 |
| GB2092001A (en) | 1982-08-11 |
| IT1170618B (it) | 1987-06-03 |
| GB2092001B (en) | 1985-01-23 |
| LU83808A1 (fr) | 1982-05-07 |
| JPS57139016A (en) | 1982-08-27 |
| DE3150527A1 (de) | 1982-08-12 |
| BE891316A (fr) | 1982-03-31 |
| FR2497667A1 (fr) | 1982-07-16 |
| JPH0155249B2 (it) | 1989-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wei et al. | Randomised trial of plasma exchange in mild systemic lupus erythematosus | |
| JP4754660B2 (ja) | 糖尿病の症状を治療する方法 | |
| Rydberg et al. | Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans | |
| Barranco et al. | Treatment of relapsing polychondritis with dapsone | |
| Horio et al. | Potassium iodide in the treatment of erythema nodosum and nodular vasculitis | |
| Giansanti et al. | Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease | |
| SK11093A3 (en) | Treatment of disease employing hyaluronic and nsaids | |
| Grasso et al. | Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage | |
| EP0695187B1 (en) | Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid | |
| WO2021244010A1 (zh) | 热休克因子2结合蛋白在肝脏缺血再灌注损伤、药物性肝损伤中的应用 | |
| NL8105073A (nl) | Farmacologische toebereiding van fructose-1,6-difosfaat met therapeutische werking op patienten met brandwonden. | |
| Higgins et al. | Regression of retinopathy by squalamine in a mouse model | |
| JP7189342B2 (ja) | 貧血治療薬の製造における抗血小板トロンボリシンの使用 | |
| JP3889844B2 (ja) | 筋萎縮性側索硬化症治療剤 | |
| JP4463885B2 (ja) | 劇症肝炎疾患治療剤 | |
| CN102526695A (zh) | 中华眼镜蛇蛇毒在治疗糖尿病及糖尿病肾病并发症中的用途 | |
| DE3786456T2 (de) | Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen. | |
| Slattery et al. | Haemoperfusion in the management of digoxin toxicity: is it warranted? | |
| CN104001152B (zh) | 脱精氨酸补体3f（DRC3f）在治疗肝损伤中的应用 | |
| AU749673B2 (en) | Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye | |
| Gimbel et al. | Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery | |
| JP6153838B2 (ja) | 血管透過性抑制剤 | |
| US3629391A (en) | Method for diagnosing diabetes | |
| JP7189399B2 (ja) | 骨髄増殖性障害を患う患者の処置のための方法及び医薬組成物 | |
| CN115590963A (zh) | 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |